Skip to main content
Equibles

MetLife Investment Management, LLC

Position in HAE — Haemonetics Corp

CIK 1529735 Whippany, NJ
Back to HAE Full portfolio

Position in HAE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,681,075
+$973,767 QoQ
Shares Held
49,081
+2.2% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#84
of 329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HAE Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $231,772,552 across 68 Medical Devices names. HAE ranks #15 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 398,341 $36,145,462
2 SYK
Stryker Corp
 78,948 $24,855,988
3 MDT
Medtronic plc
 293,703 $22,976,385
4 BRKR
Bruker Corp
 374,119 $22,514,481
5 GMED
Globus Medical Inc
 275,556 $21,771,679
6 BSX
Boston Scientific Corp
 339,986 $14,510,602
7 EW
Edwards Lifesciences Corp
 131,633 $11,907,521
8 DXCM
Dexcom Inc
 103,307 $6,957,726

All Filings in HAE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,681,075 49,081
2026-03-31 $2,707,308 48,036
2025-12-31 $3,939,612 49,153
2025-09-30 $2,553,732 52,395
2025-06-30 $24,702,401 331,087
2025-03-31 $20,116,244 316,542
2024-12-31 $4,510,369 57,766
2024-09-30 $4,382,719 54,525
2024-06-30 $4,533,934 54,804
2024-03-31 $4,493,592 52,649
2023-12-31 $4,656,618 54,457
2023-09-30 $4,917,046 54,890
2023-06-30 $4,773,459 56,066
2023-03-31 $4,671,651 56,455
2022-12-31 $4,513,094 57,382
2022-09-30 $4,316,097 58,302
2022-06-30 $3,817,136 58,563
2022-03-31 $3,798,510 60,084
2021-12-31 $2,275,203 42,896
2021-09-30 $3,008,051 42,613
2021-06-30 $2,904,837 43,590
2021-03-31 $2,914,234 26,252
2020-12-31 $3,299,587 27,786
2020-09-30 $2,532,605 29,027
2020-06-30 $2,679,814 29,922
2020-03-31 $5,022,365 50,395